FER and cervical cancer: The GX-188E, a HPV therapeutic DNA vaccine (consisting of a tissue plasminogen activator signal sequence, an FMS-like tyrosine kinase 3 ligand, and shuffled E6 and E7 genes of HPV type [50]), plus pembrolizumab showed antitumour activity against recurrent or advanced cervical cancer [51].